Bile Duct Neoplasm Market

DelveInsight's "Bile Duct Neoplasms Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Bile Duct Neoplasms , historical and forecasted epidemiology as well as the Bile Duct Neoplasms market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Bile Duct Neoplasm Companies:

  • Agios Pharmaceuticals
  • AstraZeneca
  • Merck/EMD Serono
  • QED Therapeutics
  • Nucana
  • Lexicon Pharmaceutical
  • And Many Others

View Report: https://www.delveinsight.com/report-store/bile-duct-neoplasms-market

Dermatomycoses Market

DelveInsight's "Dermatomycoses Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Dermatomycoses , historical and forecasted epidemiology as well as the Dermatomycoses market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Dermatomycoses Companies:

  • Anacor Pharmaceuticals Inc
  • Biolab Farmaceutica Ltda
  • Blueberry Therapeutics Ltd
  • Daewoong Pharmaceutical Co Ltd
  • Dermala Inc
  • Helix BioMedix Inc
  • Novan Inc
  • Sol-Gel Technologies Ltd
  • TGV-Laboratories
  • Viamet Pharmaceuticals Inc
  • Vyome Biosciences Pvt Ltd

View Report: https://www.delveinsight.com/report-store/dermatomycoses-market

Familial Primary Pulmonary Hypertension Market

DelveInsight's "Familial Primary Pulmonary Hypertension Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Familial Primary Pulmonary Hypertension , historical and forecasted epidemiology as well as the Familial Primary Pulmonary Hypertension market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Familial primary pulmonary hypertension is a rare autosomal dominant disorder that has reduced penetrance and that has been mapped to a 3-cM region on chromosome 2q33 (locus PPH1). The phenotype is characterized by monoclonal plexiform lesions of proliferating endothelial cells in pulmonary arterioles. These lesions lead to elevated pulmonary-artery pressures, right-ventricular failure, and death. Although primary pulmonary hypertension is rare, cases secondary to known etiologies are more common and include those associated with the appetite-suppressant drugs, including phentermine-fenfluramine.

View Report: https://www.delveinsight.com/report-store/familial-primary-pulmonary-hypertension-market

Intravenous Immunoglobulin Market

Intravenous immunoglobulin (also referred to as IVIG) is a product made up of antibodies that can be given intravenously. According to the American College of Rheumatology, it is prepared from a pool of immunoglobulins (antibodies) from the plasma of thousands of healthy donors.

Immunoglobulins are made by the immune system of healthy people to fight infections. While IVIG is derived from plasma (a blood product), it is so purified that the chances of contracting a blood-borne infection are extremely low.

Traditionally, IVIG has been used as replacement therapy for patients with primary or secondary immunoglobulin deficiencies.

However, increasingly, IVIG is being used (in doses higher than for replacement therapy) in certain bacterial or viral infectious diseases as well. A variety of modes of action have been attributed to the beneficial effects of IVIG, including its interaction with T-cell function, antigen-presenting cell maturation/presentation, combined with a general “tune down” effect on inflammatory reactions.

Intravenous Immunoglobulin Companies:

  • Evolve Biologics
  • Biotest
  • Momenta Pharmaceuticals
  • Green Cross Pharma
  • And Many Others

View Report: https://www.delveinsight.com/report-store/intravenous-immunoglobulin-market